December 31, 2025 · Form 4 insider transaction
Clifton R. LaDuane bought 140,667 shares of KemPharm Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 7 days after the transaction.
Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025.